A Phase II Study of the Survivin Suppressant YM155 in Patients With Refractory Diffuse Large B-Cell LymphomaCHESON, Bruce D; BARTLETT, Nancy L; VOSE, Julie M et al.Cancer. 2012, Vol 118, Num 12, pp 3128-3134, issn 0008-543X, 7 p.Article

Multicenter Phase II Trial ofYM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non―Small-Cell Lung CancerGIACCONE, Giuseppe; ZATLOUKAL, Petr; ROUBEC, Jaromir et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4481-4486, issn 0732-183X, 6 p.Article